HER2/neu peptide vaccine (Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium)

N/A

Report date: 2025/02/04 20:00:06

Base Information

Drug NameHER2/neu peptide vaccine (Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Synthetic peptide vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 antagonists
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsBreast Neoplasms, MaleBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesFred Hutchinson/University Of Washington Cancer Consortium
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Washington
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms, MaleBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A